Valproate and sodium butyrate attenuate manganese‐decreased locomotor activity and astrocytic glutamate transporters expression in mice

[1]  Min Jung Park,et al.  The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats , 2016, Journal of Neuroinflammation.

[2]  L. R. Ayres,et al.  Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta‐analyses , 2016, Pharmacotherapy.

[3]  M. Aschner,et al.  “Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies” , 2016, BMC Pharmacology and Toxicology.

[4]  Jing Sun,et al.  Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice , 2016, Brain Research.

[5]  E. Elliott,et al.  Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model , 2016, Neuropharmacology.

[6]  Zibin Gao,et al.  Glutamate Transporters/Na+, K+-ATPase Involving in the Neuroprotective Effect as a Potential Regulatory Target of Glutamate Uptake , 2016, Molecular Neurobiology.

[7]  M. Aschner,et al.  Transcriptional Regulation of the Astrocytic Excitatory Amino Acid Transporter 1 (EAAT1) via NF-κB and Yin Yang 1 (YY1)* , 2015, The Journal of Biological Chemistry.

[8]  Junjie Yu,et al.  Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice , 2015, BioMed research international.

[9]  J. Malago,et al.  Intraperitoneal administration of butyrate prevents the severity of acetic acid colitis in rats , 2015, Journal of Zhejiang University-SCIENCE B.

[10]  E. Cavalheiro,et al.  Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties , 2015, Journal of neurodegenerative diseases.

[11]  T. Harada,et al.  Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma , 2015, Neuroscience Letters.

[12]  G. Wegener,et al.  Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene , 2015, The international journal of neuropsychopharmacology.

[13]  H. Hashimoto,et al.  Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism , 2014, Pharmacology Biochemistry and Behavior.

[14]  A. Bassiouny,et al.  Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats , 2014, Front. Cell. Neurosci..

[15]  W. Zou,et al.  Repression of contexual fear memory induced by isoflurane is accompanied by reduction in histone acetylation and rescued by sodium butyrate. , 2014, British journal of anaesthesia.

[16]  Kyuwon Lee,et al.  Yin Yang 1 Is a Repressor of Glutamate Transporter Eaat2, and It Mediates Manganese-induced Decrease of Eaat2 Expression in Astrocytes Impairment of Astrocytic Glutamate Transporter (glt-1; Eaat2) Function Is Associated with Multiple Neurodegenerative Dis- Eases, including Parkinson's Disease (pd) a , 2022 .

[17]  P. Striano,et al.  Metabolic and endocrine effects of valproic acid chronic treatment , 2013, Epilepsy Research.

[18]  K. Uaesoontrachoon,et al.  Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy , 2013, PloS one.

[19]  L. Leal,et al.  Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  L. Tsai,et al.  The potential of HDAC inhibitors as cognitive enhancers. , 2013, Annual review of pharmacology and toxicology.

[21]  D. Chuang,et al.  Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder , 2013, Pharmacological Reviews.

[22]  W. Stewart,et al.  Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. , 2012, Journal of neurotrauma.

[23]  M. Marcus,et al.  X-Ray Fluorescence Imaging: A New Tool for Studying Manganese Neurotoxicity , 2012, PloS one.

[24]  J. McGann,et al.  Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo. , 2012, Neurotoxicology.

[25]  S. Yamawaki,et al.  Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[26]  C. Billington,et al.  Annals of the New York Academy of Sciences Brain Orexin Promotes Obesity Resistance , 2022 .

[27]  M. J. Dauncey,et al.  Recent advances in nutrition, genes and brain health* , 2012, Proceedings of the Nutrition Society.

[28]  Masaya Takahashi,et al.  Iron-Responsive Olfactory Uptake of Manganese Improves Motor Function Deficits Associated with Iron Deficiency , 2012, PloS one.

[29]  S. Spence,et al.  Common neurological co-morbidities in autism spectrum disorders , 2011, Current opinion in pediatrics.

[30]  R. Meli,et al.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases , 2011 .

[31]  W. Lasoń,et al.  Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update , 2011, Pharmacological reports : PR.

[32]  L. Tsai,et al.  Valproic Acid Attenuates Blood–Brain Barrier Disruption in a Rat Model of Transient Focal Cerebral Ischemia: The Roles of HDAC and MMP-9 Inhibition , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  C. Bae,et al.  Neuroprotection by valproic Acid in mouse models of permanent and transient focal cerebral ischemia. , 2010, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[34]  E. Hoffman,et al.  Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype , 2010, PloS one.

[35]  Yan Leng,et al.  Multiple roles of HDAC inhibition in neurodegenerative conditions , 2009, Trends in Neurosciences.

[36]  M. Aschner,et al.  Estrogen and tamoxifen reverse manganese‐induced glutamate transporter impairment in astrocytes , 2009, Journal of neurochemistry.

[37]  A. Contestabile,et al.  Memory-enhancing drugs: a molecular perspective. , 2009, Mini reviews in medicinal chemistry.

[38]  E. López-Bayghen,et al.  Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: Involvement of Ying-Yang 1 , 2008, Neurochemistry International.

[39]  M. Beal,et al.  Pulse Inhibition of Histone Deacetylases Induces Complete Resistance to Oxidative Death in Cortical Neurons without Toxicity and Reveals a Role for Cytoplasmic p21waf1/cip1 in Cell Cycle-Independent Neuroprotection , 2008, The Journal of Neuroscience.

[40]  M. Robinson,et al.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention , 2007, Neurochemistry International.

[41]  J. Rothstein,et al.  Variations in Promoter Activity Reveal a Differential Expression and Physiology of Glutamate Transporters by Glia in the Developing and Mature CNS , 2007, The Journal of Neuroscience.

[42]  D. Brann,et al.  Role of astrocytes in estrogen-mediated neuroprotection , 2007, Experimental Gerontology.

[43]  Christian Steinhäuser,et al.  Astrocyte dysfunction in neurological disorders: a molecular perspective , 2006, Nature Reviews Neuroscience.

[44]  Ruth Luthi-Carter,et al.  Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.

[45]  A. Hazell,et al.  Manganese Neurotoxicity: An Update of Pathophysiologic Mechanisms , 2002, Metabolic Brain Disease.

[46]  J. Garner,et al.  Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents , 2002, Behavioural Brain Research.

[47]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[48]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[49]  R. Wada,et al.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Henriksson,et al.  Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  J. Morris,et al.  Accumulation of manganese in rat brain following intranasal administration. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[52]  W. Löscher,et al.  Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting , 1993, Epilepsy Research.

[53]  M. Beal,et al.  Manganese Injection into the Rat Striatum Produces Excitotoxic Lesions by Impairing Energy Metabolism , 1993, Experimental Neurology.

[54]  A. Schousboe,et al.  The Glutamine Transporters and Their Role in the Glutamate/GABA-Glutamine Cycle. , 2016, Advances in neurobiology.

[55]  N. Sumien,et al.  Repetitive Mild Traumatic Brain Injury in a Mouse Model , 2016 .

[56]  M. Norenberg,et al.  Glutamine Synthetase: Role in Neurological Disorders. , 2016, Advances in neurobiology.

[57]  M. Zhang,et al.  The Behavioral Assessment of Sensorimotor Processes in the Mouse: Acoustic Startle, Sensory Gating, Locomotor Activity, Rotarod, and Beam Walking , 2009 .

[58]  A. Contestabile,et al.  Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. , 2009, Current molecular pharmacology.

[59]  Kenneth M Heilman,et al.  Daily ambulatory activity levels in idiopathic Parkinson disease. , 2008, Journal of rehabilitation research and development.

[60]  J. Roth.  Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. , 2006, Biological research.

[61]  J. Rothstein.  Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. , 1995, Clinical neuroscience.